Limited Competition: Consortia for HIV/AIDS and Alcohol-Related Research Trials (CHAART) Project (Collaborative U01)

The summary for the Limited Competition: Consortia for HIV/AIDS and Alcohol-Related Research Trials (CHAART) Project (Collaborative U01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Limited Competition: Consortia for HIV/AIDS and Alcohol-Related Research Trials (CHAART) Project (Collaborative U01): The overall goal of this This Funding Opportunity Announcement (FOA) is to advance operations or implementation research in the context of alcohol and HIV/AIDS 1) to continue to develop a broader systems approach for monitoring complex HIV and alcohol-related morbidity and mortality and 2) to intervene to reduce the impact of alcohol and HIV disease progression and transmission. This proposed research initiative is aligned with the research priorities set forth in the Trans-NIH Plan for HIV-Related Research. The purpose of this FOA is to solicit applications for research projects as part of the consortia on HIV/AIDS and alcohol-related outcomes research.

Federal Grant Title:	Limited Competition: Consortia for HIV/AIDS and Alcohol-Related Research Trials (CHAART) Project (Collaborative U01)
Federal Agency Name:	National Institutes of Health
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-AA-16-001
Type of Funding:	Cooperative Agreement
CFDA Numbers:	93.273
CFDA Descriptions:	Alcohol Research Programs
Current Application Deadline:	Jan 15, 2016
Original Application Deadline:	Jan 15, 2016
Posted Date:	Jul 8, 2015
Creation Date:	Jul 8, 2015
Archive Date:	Feb 15, 2016
Total Program Funding:	$7,000,000
Maximum Federal Grant Award:	$500,000
Minimum Federal Grant Award:	none
Expected Number of Awards:	15
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: Private institutions of higher education
Public and State controlled institutions of higher education
Additional Information on Eligibility: Other Eligible Applicants include the following:
Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/rfa-files/RFA-AA-16-001.html
Grant Announcement Contact: NIH OER Webmaster [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

National Institutes of Health 301-496-3405
Similar Government Grants: • Limited Competition: Alcohol-associated Hepatitis Clinical Network Integrated Treatment C...; • Limited Competition: Alcohol-associated Hepatitis Clinical Network Integrated Treatment C...; • Model Continuums of Care Initiative (MCCI) to Advance Health Equity and End Health Dispari...; • Limited Competition: Collaborative Study on the Genetics of Alcoholism (COGA) (U10 Clinica...; • Pilot and Feasibility Studies in Preparation for Substance Use Prevention Trials (R34 Clin...; • Mechanisms of Alcoholic Pancreatitis; • Alcohol Abuse and Hiv/Aids in Resource-Poor Societies; • Mechanisms of Alcohol-Induced Tissue Injury
More Grants from the National Institutes of Health: • SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies...; • Small Business Transition Grant For Early Career Scientists (R41/R42 Clinical Trial Not Al...; • Cystic Fibrosis Research and Translation Centers (P30 Clinical Trial Optional); • Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial No...; • Mentored Quantitative Research Development Award (Parent K25 Independent Basic Experimenta...